MarketInOut Stock Screener Log In | Sign Up

Neuland Laboratories Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:52
Neuland Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization256,213 mln
Float7.20 mln
Earnings Date11/03/2026

EPS

388
Stretched

P / E

51.47
Richly valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.11
Caution advised

1-Year Forecast

24,678
Attractive

Relative Strength

68 / 100
Outperforming

Business Description

Founded in 1984 and based in Hyderabad, India, Neuland Laboratories Limited produces and sells pharmaceutical ingredients to customers across India, Europe, the United States, and other global markets. The company also offers specialized manufacturing services, including the production of peptides for clients who require tailored solutions.

Key Fundamentals

EPS388
P/E51.47
ROE29.75
RPS1,849
ROIC25.44
ROA19.51
Interest Cover25.24
EBITDA, mln7,937
EV / EBITDA34.52
EV / EBIT39.39
Revenue, mln23,718
EV / Revenue11.55

Quote Details

Last 19,970
Change 655 (3.39%)
Open 19,200
Volume 31,727
Turnover 633,588,160
Average Volume 43,738

Financial Ratios

Pre-Tax Profit Margin28
Current Ratio2.09
Price / Book14.62
Price / Tangible Book17.26
Debt / Equity0.16
Price / Sales11.56
PEG Ratio1.62

Financial Strength

Altman Z-Score18.04
Piotroski F-Score 6 / 9
Beneish M-Score-2.11
Price to Intrinsic Value12.39
Price to Lynch Fair Value2.20
Price to Graham Number7.60
1-Year Target Price24,678
Shiller PE Ratio148

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.24% 91 / 100   
1 Month -8.77% 43 / 100   
2 Months 5.89% 79 / 100   
6 Months 35.6% 88 / 100   
1 Year 22.89% 83 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog